Data science startup Pachyderm, which just raised $16

Data science startup Pachyderm, which just raised $16 million, says remote work has been a 'a massive benefit' to its business

Business Insider

Published 19 Aug 2020

· The data science platform Pachyderm raised $16 million in Series B funding led by Microsoft's venture fund M12, it announced Wednesday.
· Pachyderm offers a free, community version of its software that anyone can use and download for free, as well as a paid business version.
· Pachyderm cofounder Joey Zwicker says the...

Full Article

Data science startup Pachyderm, which just raised $16 million, says remote work has been a 'a massive benefit' to its business

Data science startup Pachyderm, which just raised $16 million, says remote work has been a 'a massive benefit' to its business

You might like

Related news coverage

Commercial real-estate markets have been turned upside down. These are the new winners and losers — and the key deals to keep an eye on.

Profitable Australian DevOps startup BuildKite explains how its new $28 million in funding will let it spread the word about being 'the best-kept secret in the developer tool space'

POWER PLAYERS: Meet the 18 executives and scientists at Google Health who are shaping the future of the tech giant's healthcare business

POWER PLAYERS: Meet the 15 execs at Mastercard driving an ambitious push into new businesses built on cybersecurity, data, and analytics

We asked 7 alt data leads at big names like Bridgewater, Point72, and Man Group how to pitch them on new data feeds. Here's how to win them over.

Advertisement

More coverage

10 healthcare startups that could be M&A targets after Teladoc's record-breaking $18.5 billion deal for Livongo

Batteries, fusion, and hydropower: Meet the 25 startups that Bill Gates is betting on to revolutionize the future of energy

Meet the 13 power players of fintech unicorn Brex as it tries to unseat traditional banks and credit card companies in 2020

Secretive data-analytics firm Palantir Technologies has thrived in the shadows, but a coming IPO could poke holes in its most valuable asset — its reputation

NA Proactive news snapshot: Media Central Corporation, DGTL Holdings, Binovi Technologies, Innocan Pharma, Agile Therapeutics, CytoDyn ... UPDATE